Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

A rapid and convenient method to enhance transgenic expression in target cells.

Chen CH, Liu YK, Lin YL, Chuang HY, Hsu WT, Chiu YH, Cheng TL, Liao KW.

Prep Biochem Biotechnol. 2012;42(5):448-61. doi: 10.1080/10826068.2011.644013.

PMID:
22897767
2.

Dual-targeted polyplexes: one step towards a synthetic virus for cancer gene therapy.

Nie Y, Schaffert D, Rödl W, Ogris M, Wagner E, Günther M.

J Control Release. 2011 May 30;152(1):127-34. doi: 10.1016/j.jconrel.2011.02.028.

PMID:
21392549
3.

Integrin targeting using RGD-PEI conjugates for in vitro gene transfer.

Kunath K, Merdan T, Hegener O, Häberlein H, Kissel T.

J Gene Med. 2003 Jul;5(7):588-99.

PMID:
12825198
4.

Integrin alphaVbeta3 targeted gene delivery using RGD peptidomimetic conjugates with copolymers of PEGylated poly(ethylene imine).

Merkel OM, Germershaus O, Wada CK, Tarcha PJ, Merdan T, Kissel T.

Bioconjug Chem. 2009 Jun;20(6):1270-80. doi: 10.1021/bc9001695.

PMID:
19476331
6.

Experimental treatment of ovarian cancers by adenovirus vectors combining receptor targeting and selective expression of tumor necrosis factor.

Murugesan SR, Akiyama M, Einfeld DA, Wickham TJ, King CR.

Int J Oncol. 2007 Oct;31(4):813-22.

PMID:
17786312
7.
8.

An angiogenic, endothelial-cell-targeted polymeric gene carrier.

Suh W, Han SO, Yu L, Kim SW.

Mol Ther. 2002 Nov;6(5):664-72.

PMID:
12409265
9.

Virus-mimetic polyplex particles for systemic and inflammation-specific targeted delivery of large genetic contents.

Kang S, Lu K, Leelawattanachai J, Hu X, Park S, Park T, Min IM, Jin MM.

Gene Ther. 2013 Nov;20(11):1042-52. doi: 10.1038/gt.2013.29.

PMID:
23759703
11.

Osteopontin promotes a cancer stem cell-like phenotype in hepatocellular carcinoma cells via an integrin-NF-κB-HIF-1α pathway.

Cao L, Fan X, Jing W, Liang Y, Chen R, Liu Y, Zhu M, Jia R, Wang H, Zhang X, Zhang Y, Zhou X, Zhao J, Guo Y.

Oncotarget. 2015 Mar 30;6(9):6627-40.

12.

A chitosan-graft-PEI-candesartan conjugate for targeted co-delivery of drug and gene in anti-angiogenesis cancer therapy.

Bao X, Wang W, Wang C, Wang Y, Zhou J, Ding Y, Wang X, Jin Y.

Biomaterials. 2014 Sep;35(29):8450-66. doi: 10.1016/j.biomaterials.2014.06.025.

PMID:
24997481
13.
14.

Novel biotinylated chitosan-graft-polyethyleneimine copolymer as a targeted non-viral vector for anti-EGF receptor siRNA delivery in cancer cells.

Darvishi MH, Nomani A, Amini M, Shokrgozar MA, Dinarvand R.

Int J Pharm. 2013 Nov 18;456(2):408-16. doi: 10.1016/j.ijpharm.2013.08.069.

PMID:
24012865
16.

Glutathione-sensitive RGD-poly(ethylene glycol)-SS-polyethylenimine for intracranial glioblastoma targeted gene delivery.

Lei Y, Wang J, Xie C, Wagner E, Lu W, Li Y, Wei X, Dong J, Liu M.

J Gene Med. 2013 Aug-Sep;15(8-9):291-305. doi: 10.1002/jgm.2726.

PMID:
24038955
17.

RGD targeting hyaluronic acid coating system for PEI-PBLG polycation gene carriers.

Tian H, Lin L, Chen J, Chen X, Park TG, Maruyama A.

J Control Release. 2011 Oct 10;155(1):47-53. doi: 10.1016/j.jconrel.2011.01.025.

PMID:
21281679
18.

Cyclic RGD-poly(ethylene glycol)-polyethyleneimine is more suitable for glioblastoma targeting gene transfer in vivo.

Zhan C, Qian J, Feng L, Zhong G, Zhu J, Lu W.

J Drug Target. 2011 Aug;19(7):573-81. doi: 10.3109/1061186X.2010.542244.

PMID:
21166603
19.

Increasing cancer-specific gene expression by targeting overexpressed α5β1 integrin and upregulated transcriptional activity of NF-κB.

Adil MM, Levine RM, Kokkoli E.

Mol Pharm. 2014 Mar 3;11(3):849-58. doi: 10.1021/mp400535v.

PMID:
24483950
Items per page

Supplemental Content

Support Center